ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 87 filers reported holding ONCOMED PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $351,000 | -64.3% | 151,879 | -50.9% | 0.01% | -68.4% |
| Q1 2018 | $983,000 | -23.7% | 309,217 | -1.7% | 0.02% | -24.0% |
| Q4 2017 | $1,289,000 | -9.1% | 314,465 | +0.2% | 0.02% | -16.7% |
| Q3 2017 | $1,418,000 | +29.4% | 313,775 | -4.7% | 0.03% | +30.4% |
| Q2 2017 | $1,096,000 | -63.3% | 329,100 | +1.5% | 0.02% | -65.7% |
| Q1 2017 | $2,987,000 | +18.5% | 324,350 | -0.8% | 0.07% | +15.5% |
| Q4 2016 | $2,520,000 | -26.7% | 326,900 | +8.6% | 0.06% | -29.3% |
| Q3 2016 | $3,440,000 | -8.6% | 300,925 | -1.5% | 0.08% | -13.7% |
| Q2 2016 | $3,762,000 | +20.5% | 305,625 | -1.1% | 0.10% | +20.3% |
| Q1 2016 | $3,123,000 | -55.1% | 308,950 | +0.1% | 0.08% | -54.9% |
| Q4 2015 | $6,956,000 | +35.2% | 308,600 | -0.5% | 0.18% | +32.6% |
| Q3 2015 | $5,145,000 | – | 310,150 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|